Teva gets approval to buy Bentley

Teva Pharmaceutical Industries received nearly a 69 percent shareholder approval to complete its $360 million dollar purchase of Bentley Pharmaceuticals, a move the company hopes will help it to expand sales in Spain with over 170 products. Report.

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.